G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
0 hedge funds and large institutions have $0 invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $32.6K → $0 (-$32.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$20.4K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$12K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$169 |
GMVD Hedge Fund Activity: Q4 2023 in Review
0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q4 2023, worth a combined $0 — down 100% from $32.6K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GMVD and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $20.4K sold.
- 0 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q4 2023, down from 3 in Q3 2023.
- Funds reported $0 of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q4 2023 and 3 closed out, a net change of -3 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q4 2023 was Sabby Management, an estimated $20.4K sold.
Based on aggregated 13F filings for Q4 2023.